europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

Abolis joins the EuropaBio 25th Anniversary in 2021

29/03/2021
PRESS RELEASE

Abolis joins the EuropaBio 25th Anniversary in 2021

Brussels, Belgium – March 29 2021 – EuropaBio today announced that Abolis, a fast-growing French biotech company specialized in enabling the biosynthesis of sustainable molecules for food & feed, cosmetics, flavours & fragrances, specialty chemicals and pharmaceuticals via advanced microbial strain engineering, has joined EuropaBio’s 25th Anniversary Celebration Programme as a sponsor.

With a mission to celebrate the most significant scientific and commercial advances in European biotechnology over the last 25 years, Europe’s leading life sciences industry association commenced its quarter century anniversary celebrations in March with the launch of a dedicated website at www.europabio25.org.

During 2021, EuropaBio, together with its members and partners, will nominate the most impactful cross-sector developments from the last 25 years and showcase how they have benefited society and the environment. The commemoration of 25 years of scientific advances will be amplified through webinars, interviews, and reviews discussing some of the key drivers of biotechnology innovation. The year’s programme of celebratory events will end in December with a gala evening in Brussels and the presenting of the 2021 SME Award from EuropaBio.

In joining the EuropaBio programme, Abolis will bring its synbio capabilities and its molecular biology, fermentation, robotics and analytics expertise to the celebrations. Abolis will lead the selection committee for industrial biotechnology nominations and also award the delegate-selected prize for best industrial biotech advance in the last 25 years at the EFIB conference in Vienna, in October.

Dr Claire Skentelbery, Director General of EuropaBio commented, “We are absolutely delighted to welcome Abolis to our 25th anniversary celebrations. It is the perfect example of how Europe builds a competitive future across all sectors from biotechnology.

“Industrial biotechnology holds the key to a circular bioeconomy and sustainable competitive industry for Europe, which will strongly benefit citizens and producers. They will have access to more sustainably produced ingredients and products and it will be European industry producing them once more” commented Abolis CEO Cyrille Pauthenier. “EuropaBio’s 25th Anniversary is the ideal platform to showcase what biotechnology can deliver and how it will continue to grow”.

Join in the EuropaBio anniversary celebrations for the whole of 2021 through our newsletter and visit the dedicated Anniversary website at www.europabio25.org.

Download the full PRESS RELEASE below.

Event Banners (9)

Abolis joins the EuropaBio 25th Anniversary in 2021


Download
2021_03_G_PR_Abolis-Sponsor-for-EuropaBio-25th-AnniversaryDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

23/03/2023

Unlocking the Potential of Biotechnology Innovation for Patients


Read more
16/03/2023

Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future


Read more
07/03/2023

Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders


Read more
06/03/2023

Can the Pharmaceutical Strategy Deliver for Europe?


Read more

Important links

  • Unlocking the Potential of Biotechnology Innovation for Patients
  • Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies